BROOKE REICHENBACH: Open Payments
NPI 1871115212 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 11 payments from 10 companies in 2025. Trend: 2023 $200 · 2024 $344 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $36 |
| Seqirus USA Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, Flexitouch Plus, Flucelvax, Veozah, AIRSUPRA, SPRAVATO, Cologuard Collection Kit, Ozempic.
Industry payments across DE — which companies pay providers there.
